Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER

Updated draft evidence report maintains the benefit is small with higher price tag

- PMLiVE

New faces at Lucid Group and ZPB Associates

Latest movers in healthcare comms

- PMLiVE

ChemoCentryx surges on phase 3 vasculitis study

Shares in the US biotech rose 227% after announcing trial results

- PMLiVE

Q&A: Vicky Bramham

PME interviews OPEN Health Patient & Brand Communications' managing director, PR

Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....

OPEN Health

- PMLiVE

Bedrock’s on fire for Wellbeing Week

Bedrock creates a positive working environment to enable individuals and our business to thrive.

Bedrock Healthcare Communications

- PMLiVE

CymaBay Therapeutics plummets after abandoning NASH drug

Failure of mid-stage liver disease candidate caused shares to slip over 75%

- PMLiVE

FDA backs GBT’s sickle cell drug Oxbryta

Second new treatment for blood disorder to be approved this year

Teva Pharma logo

Teva among generic drugmakers hoping to settle US antitrust probe

A number of companies are accused of colluding on drug prices

- PMLiVE

Private equity firm backs Ferring gene therapy venture

Joint venture will focus on development of therapies for bladder cancer

AI: opportunities and barriers to improving healthcare

How AI is shaping the future of healthcare

Is competition the enemy of progress and collaboration the ally of success?

By Jessica Pacey, CEO, 67health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links